Biomagnetics Diagnos Current Ratio vs. Earnings Per Share

BMGPDelisted Stock  USD 0.0001  0.00  0.00%   
Based on Biomagnetics Diagnos' profitability indicators, Biomagnetics Diagnos may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Biomagnetics Diagnos' ability to earn profits and add value for shareholders.
For Biomagnetics Diagnos profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biomagnetics Diagnos to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biomagnetics Diagnos utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biomagnetics Diagnos's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biomagnetics Diagnos over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Please note, there is a significant difference between Biomagnetics Diagnos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomagnetics Diagnos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomagnetics Diagnos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biomagnetics Diagnos Earnings Per Share vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biomagnetics Diagnos's current stock value. Our valuation model uses many indicators to compare Biomagnetics Diagnos value to that of its competitors to determine the firm's financial worth.
Biomagnetics Diagnos is number one stock in current ratio category among its peers. It also is number one stock in earnings per share category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Biomagnetics Diagnos by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Biomagnetics Earnings Per Share vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Biomagnetics Diagnos

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
0.02 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Biomagnetics Diagnos

Earnings per Share

 = 

Earnings

Average Shares

 = 
(0.01) X
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.

Biomagnetics Earnings Per Share Comparison

Biomagnetics Diagnos is currently under evaluation in earnings per share category among its peers.

Biomagnetics Diagnos Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biomagnetics Diagnos, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biomagnetics Diagnos will eventually generate negative long term returns. The profitability progress is the general direction of Biomagnetics Diagnos' change in net profit over the period of time. It can combine multiple indicators of Biomagnetics Diagnos, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Biomagnetics Diagnostics Corporation, a medical device and biotechnology company, designs, patents, and markets diagnostic equipment and immunoassays, and other biotechnologies. The company was founded in 1997 and is based in Orangevale, California. Biomagnetics Diagnos is traded on OTC Exchange in the United States.

Biomagnetics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biomagnetics Diagnos. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biomagnetics Diagnos position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biomagnetics Diagnos' important profitability drivers and their relationship over time.

Use Biomagnetics Diagnos in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomagnetics Diagnos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomagnetics Diagnos will appreciate offsetting losses from the drop in the long position's value.

Biomagnetics Diagnos Pair Trading

Biomagnetics Diagnos Pair Trading Analysis

The ability to find closely correlated positions to Biomagnetics Diagnos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomagnetics Diagnos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomagnetics Diagnos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomagnetics Diagnos to buy it.
The correlation of Biomagnetics Diagnos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomagnetics Diagnos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomagnetics Diagnos moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomagnetics Diagnos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biomagnetics Diagnos position

In addition to having Biomagnetics Diagnos in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Social Domain Thematic Idea Now

Social Domain
Social Domain Theme
New or established large and mid-sized companies that are involved in the social media industry, including entities that provide web-based or mobile media applications and services across across large segment of population in multiple geographical areas. The Social Domain theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Social Domain Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Biomagnetics Stock

If you are still planning to invest in Biomagnetics Diagnos check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biomagnetics Diagnos' history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing